Can you provide the last earnings date for QUANTUM BIOPHARMA-B SUB VOT?
QUANTUM BIOPHARMA-B SUB VOT (QNTM) last reported earnings on 3/26/2026.
NASDAQ:QNTM • CA74764Y2050
Past quarterly earnings results for QUANTUM BIOPHARMA-B SUB VOT (QNTM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.71 | - | - | - | - | |||
| Q3 2025 | - | - | - | - | ||||
| Q2 2025 | - | - | - | - | ||||
| Q1 2025 | - | - | - | - | ||||
| Q4 2024 | - | - | - | - | ||||
| Q3 2024 | - | - | - | - | ||||
| Q2 2024 | - | - | - | - | ||||
| Q1 2024 | - | - | - | - | ||||
| Q4 2023 | - | - | - | - | ||||
| Q3 2023 | - | - | - | - | ||||
| Q2 2023 | - | - | - | - | ||||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | - | - | - | - | ||||
| Q3 2022 | - | - | - | - | ||||
| Q2 2022 | - | - | - | - | ||||
| Q1 2022 | - | - | - | - | ||||
| Q4 2021 | - | - | - | - | ||||
| Q3 2021 | - | - | - | - | ||||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | -22.04 | -92.82 | 76.26% | - | - | - | ||
| Q3 2020 | -89.05 | -47.40 | -87.85% | - | - | - | ||
| Q2 2020 | -43.55 | -73.59 | 40.82% | - | - | - | ||
| Q1 2020 | - | - | - | - |
Notes
QUANTUM BIOPHARMA-B SUB VOT (QNTM) last reported earnings on 3/26/2026.
QUANTUM BIOPHARMA-B SUB VOT (QNTM) missed EPS estimates and missed revenue estimates in the most recent quarter.